BioNTech SE (BNTX) Non-Current Debt (2018 - 2026)

BioNTech SE has reported Non-Current Debt for 8 years, with the latest figure at $361.0 million in Q4 2025.

• Quarterly Non-Current Debt rose 29.13% year-over-year to $361.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $361.0 million (up 29.13% YoY) and the FY2025 annual result came in at $350.4 million, up 25.33% from the prior year.
• Non-Current Debt rose to $361.0 million in Q4 2025 per BNTX's latest filing, from $279.5 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $361.0 million in Q4 2025 and troughed at $6.2 million in Q4 2022.
• A 5-year average of $178.4 million and a median of $203.3 million in 2021 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2022 and 2023: Non-Current Debt plunged 96.94% in 2022, then soared 570.79% in 2023.
• Over 5 years, Non-Current Debt stood at $203.3 million in 2021, then slumped by 96.94% to $6.2 million in 2022, then jumped by 570.79% to $41.7 million in 2023, then soared by 569.62% to $279.5 million in 2024, then gained by 29.13% to $361.0 million in 2025.
• According to Business Quant data, Non-Current Debt over the past three periods registered $361.0 million, $279.5 million, and $41.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.